Atara Biotherapeutics
ATRA
ATRA
125 hedge funds and large institutions have $298M invested in Atara Biotherapeutics in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 52 increasing their positions, 42 reducing their positions, and 22 closing their positions.
Holders
125
Holders Change
-14
Holders Change %
-10.07%
% of All Funds
2%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
8
Increased
52
Reduced
42
Closed
22
Calls
$4.86M
Puts
$77K
Net Calls
+$4.78M
Net Calls Change
-$324K
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$4.17M |
2 |
BG
2
Baupost Group
Boston,
Massachusetts
|
$26.5M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$6.53M |
4 |
4
Bank of America
Charlotte,
North Carolina
|
$3.52M |
5 |
5
D.E. Shaw & Co
New York
|
$12.3M |